Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials

Ambrish Singh, Benny Antony(University of Tasmania), Ashish Jacob Mathew(Christian Medical College, Vellore), Debashish Danda(Christian Medical College, Vellore), Salman Hussain(European CanCer Organisation), Shaheen E Lakhan(Global Neuroscience Initiative Foundation), Abul Kalam Najmi(Jamia Hamdard), Ruchika Goel(Christian Medical College, Vellore), Belzik Tajudheen
Modern Rheumatology
January 31, 2020
10.1080/14397595.2020.1724671
Cited by 11

Related Papers

Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
|The Lancet|2021|1.7k
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|1.7k
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|632
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|373
Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|370